AGEN
Price
$8.24
Change
+$0.15 (+1.85%)
Updated
Sep 3 closing price
Capitalization
370.65M
67 days until earnings call
Intraday BUY SELL Signals
RNAZ
Price
$2.06
Change
+$0.05 (+2.49%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
2.15M
Intraday BUY SELL Signals
Interact to see
Advertisement

AGEN vs RNAZ

AGEN vs RNAZ Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AGEN vs. RNAZ commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Hold and RNAZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2026
Stock price -- (AGEN: $8.24 vs. RNAZ: $2.15)
Brand notoriety: AGEN and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 16% vs. RNAZ: 177%
Market capitalization -- AGEN: $370.65M vs. RNAZ: $2.18M
AGEN [@Biotechnology] is valued at $370.65M. RNAZ’s [@Biotechnology] market capitalization is $2.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $141.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 1 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 1 green, 4 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, AGEN is a better buy in the long-term than RNAZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 3 TA indicator(s) are bullish while RNAZ’s TA Score has 2 bullish TA indicator(s).

  • AGEN’s TA Score: 3 bullish, 5 bearish.
  • RNAZ’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, RNAZ is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а +5.51% price change this week, while RNAZ (@Biotechnology) price change was -5.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.14%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +2267.37%.

Reported Earning Dates

AGEN is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($371M) has a higher market cap than RNAZ($2.15M). AGEN has higher P/E ratio than RNAZ: AGEN (2.75) vs RNAZ (0.00). AGEN YTD gains are higher at: 162.420 vs. RNAZ (-70.571). AGEN has higher annual earnings (EBITDA): 127M vs. RNAZ (-39.81M). AGEN has more cash in the bank: 35M vs. RNAZ (12.8M). RNAZ has less debt than AGEN: RNAZ (0) vs AGEN (41.1M). AGEN has higher revenues than RNAZ: AGEN (124M) vs RNAZ (0).
AGENRNAZAGEN / RNAZ
Capitalization371M2.15M17,264%
EBITDA127M-39.81M-319%
Gain YTD162.420-70.571-230%
P/E Ratio2.750.00230,090%
Revenue124M0-
Total Cash35M12.8M273%
Total Debt41.1M0-
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGENRNAZ
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signal:
Gain/Loss:
RNAZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SWK96.892.38
+2.52%
Stanley Black & Decker
ECO69.021.06
+1.56%
Okeanis Eco Tankers Corp
OVID2.71-0.05
-1.81%
Ovid Therapeutics
SERA2.01-0.07
-3.37%
Sera Prognostics
SLXN0.35-0.02
-5.11%
Silexion Therapeutics Corp.